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Background: This study aimed at investigating whether impaired fasting glucose (IFG) is an independent risk factor
for incident hypertension among middle-aged Japanese subjects with optimal blood pressure (OBP).
Findings: This retrospective cohort study was conducted in 2943 non-diabetic and non-hypertensive subjects
aged 40–64 years, who participated in a voluntary health check-up program during the baseline (1998–2002) and
follow-up periods (2002–2006). A multiple logistic regression model was utilized to calculate the odds ratio (OR) of
incident hypertension among men and women with IFG and OBP. OBP was defined as systolic blood pressure
(SBP) <120 mmHg and diastolic blood pressure (DBP) <80 mmHg, with no known history of hypertension. In this
study, hypertension was defined as SBP ≥140 mmHg and DBP ≥90 mmHg or by a self-reported clinical diagnosis of
hypertension. After the mean follow-up period of 5.6 years, the incidence of hypertension in men and women was
5.7% (73/1270) and 3.8% (62/1673), respectively. The age-adjusted ORs for incident hypertension in men and
women with IFG were 1.95 (95% CI, 1.21–3.15) and 3.54 (95% CI, 2.00–6.27), respectively. After adjusting for age,
systolic blood pressure, body mass index, total cholesterol, triglyceride, high-density lipoprotein cholesterol, and
uric acid, the ORs for hypertension were 1.66 (95% CI; 1.02–2.70) for men and 2.62 (95% CI, 1.45–4.73) for women.
Conclusion: The study results show that IFG may act as an independent risk factor for developing hypertension
in individuals with OBP.
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Hypertension and diabetes are the leading morbidities
affecting the general population, often concurrently, as
there is substantial overlap between hypertension and
diabetes in both etiology and disease mechanism [1-3].
The association between elevated blood pressure and
dysglycemia has also recently been of interest [4].
In 1997, the American Diabetes Association (ADA)
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reproduction in any medium, provided the ordefined as a fasting plasma glucose (FPG) level of 110–
125 mg/dL (IFG1997), to describe a prediabetic state of
dysglycemia [5]. Accordingly, researchers began to exam-
ine whether IFG may be an independent risk factor for the
development of hypertension as well. However, previous
findings were inconsistent [6-10]. Although IFG and
elevated FPG emerged as independent risk factors for the
development of hypertension in 3 prospective studies
[6-8], this relationship was not found in 2 other studies
after adjusting for body mass index (BMI) or waist
circumference [9,10].
Central obesity is a well-known risk factor for both
diabetes and hypertension [3,11], and is thought to be atd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[1,2]. Simone et al. reported that abdominal obesity was
a major predictor of the development of hypertension
even at optimal blood pressure (OBP) [8], which sug-
gests that atherogenic risk factors could play a major
role in atherosclerosis even when blood pressure is low
or at optimal levels.
The association of IFG and hypertension in those with
OBP has not been investigated thoroughly. Furthermore,
although the ADA lowered the FPG concentration range
for diagnosis of IFG from 110–125 mg/dL to 100–125
mg/dL in 2003 [9], there have been no studies con-
ducted to determine whether this new criterion for IFG
is predictive of the development of hypertension.
In this study, we investigated whether the new criter-
ion for IFG could be considered as an independent risk
factor for incident hypertension among healthy middle-
aged Japanese subjects with OBP.
Methods
Study subjects
We used a health screening program cohort of 13,734
healthy middle-aged Japanese subjects, who received
routine medical check-ups during the baseline period
between April 1998 and March 2002 at the Yuport
Medical Checkup Centre in Tokyo, which has been
described previously [12-15]. If subjects received more
than 1 check-up during the baseline period, the initial
check-up data were used. The 4-year follow-up period
ended between April 2002 and March 2006, and the
6,290 subjects who did not have follow-up data were
excluded. If subjects received more than 1 check-up
during the follow-up period, all data were used to identify
incident hypertension. This study excluded 424 subjects
who had a baseline FPG ≥126 mg/dL, HbA1c ≥6.5%, or
self-reported clinically diagnosed diabetes, as well as 4067
subjects with a baseline SBP ≥120 mmHg, DBP ≥80
mmHg, or self-reported clinical diagnosis of hypertension.
The remaining 2943 non-diabetic and non-hypertensive
patients were included as study subjects (mean follow-up,
5.6 ± 1.6 years).
Clinical and laboratory procedures
All medical check-ups followed the same procedures
during both the baseline and follow-up periods. Resting
blood pressure was measured twice by well-trained
nurses using a mercury column sphygmomanometer,
after each subject sat quietly for at least 5 min. The
average of the 2 measurements was used for analysis.
All blood samples were collected after an overnight
fast. Blood samples were measured on the same autoa-
nalyzer in the laboratory at the medical center. Plasma
glucose levels were measured using the hexokinase-
G6PD method (Denka Seiken, Niigata, Japan) with aninterassay coefficient of variation (CV) ≤3.0%. Hemo-
globin A1c (HbA1c) levels were measured using a latex
immunoagglutination assay method (Determiner HbA1c,
Kyowa Medex, Tokyo, Japan) with an interassay CV of
1.7–2.1%, which was aligned with the units used by the
Japan Diabetes Society (JDS). The JDS value for HbA1c
was converted into National Glycohemoglobin Standar-
dization Program (NGSP) units in this study, which was
calculated by the formula: HbA1c (NGSP) =HbA1c (JDS)
+ 0.4 [14]. Other blood tests, total cholesterol (TC), high-
density lipoprotein cholesterol (HDL-C), triglycerides
(TG), creatinine (Cr), and uric acid (UA), were measured
using enzymatic methods (reagents supplied by Daiichi
Pure Chemicals, Tokyo, Japan). Low-density lipoprotein
cholesterol (LDL-C) was calculated by the Friedewald
equation [16].
In accordance with the Private Information Protection
Law, information that might identify subjects was kept
confidential. This study was approved by the review
board of the Yuport Medical Checkup Centre, and
informed consent for anonymous participation in this
study was obtained from each subject at every check-up.
Diagnosis of hypertension and IFG
The Seventh Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure (JNC 7) criteria were utilized [17] to define
OBP as SBP <120 mmHg and DBP <80 mmHg. Hyperten-
sion was defined as SBP ≥140 mmHg and DBP ≥90 mmHg,
or as self-reported clinically diagnosed hypertension. FPG
categories were defined by using the 2003 ADA criteria
[18] as normal fasting glucose (NFG); FPG ≤99 mg/dL
and IFG; FPG of 100–125 mg/dL.
Statistical analysis
Baseline characteristics for all subjects are presented as
mean ± standard deviation (SD). A Students t-test or
chi-square test was used to test for differences in mean
values and frequencies between men and women. We
calculated the odds ratios (ORs) and 95% confidence
intervals (CIs) to assess the association between IFG
(versus NFG) at baseline and the incidence of hyper-
tension at follow-up using multiple logistic regression
analyses. We used two multivariable models: model 1,
adjusted for age; and model 2, adjusted for age, BMI,
SBP, TC, TG, HDL-C and UA. All reported P-values
were two-tailed, and P < 0.05 was considered statistically
significant. All statistical analyses were performed using
SPSS version 19 (SPSS Inc., Japan).
Results
The baseline characteristics of subjects and the develop-
ment of hypertension by sex are given in Table 1. Women
were older and had significantly lower SBP, DBP, TG, Cr,
Table 1 Baseline characteristics and incidence of
hypertension
Total Men Women





Age (years) 51.7 ± 6.7 51.0 ± 6.7 52.2 ± 6.7 <0.001
BMI (kg/m2) 22.1 ± 2.6 22.7 ± 2.6 21.5 ± 2.6 <0.001
SBP (mmHg) 107.5 ± 7.9 108.8 ± 7.2 106.5 ± 8.3 <0.001
DBP (mmHg) 65.8 ± 6.2 67.5 ± 5.6 64.5 ± 6.4 <0.001
FPG (mg/dL) 92.8 ± 8.5 96.1 ± 8.5 90.4 ± 7.5 <0.001
HbA1c (%) 5.4 ± 0.4 5.4 ± 0.4 5.4 ± 0.4 0.517
TC (mg/dL) 201.6 ± 33.7 194.8 ± 32.5 206.7 ± 33.7 <0.001
TG (mg/dL) 102.6 ± 62.0 124.8 ± 76.3 85.7 ± 40.9 <0.001
HDL-C (mg/dL) 60.3 ± 15.6 52.7 ± 13.3 66.0 ± 14.7 <0.001
LDL-C (mg/dL) 120.8 ± 30.1 117.1 ± 30.2 123.6 ± 30.8 <0.001
Cr (mg/dL) 0.70 ± 0.15 0.82 ± 0.13 0.61 ± 0.09 <0.001
UA (mg/dL) 5.0 ± 1.3 5.9 ± 1.2 4.4 ± 0.9 <0.001
Follow-up (years) 5.6 ± 1.6 5.7 ± 1.5 5.5 ± 1.6 <0.001
HT (%) 135 (4.6%) 73 (5.7%) 62 (3.7%) 0.010
Data are presented as mean ± SD or number (%).
*Mean or frequency (%) difference between men and women.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood
pressure; FPG, fasting plasma glucose; HbA1c, glycosylated hemoglobin; TC,
total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein cholesterol;
LDL-C, low density lipoprotein cholesterol; Cr, creatinine; UA, uric acid;
HT, hypertension.
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than men. The HbA1c level was not statistically different
between the sexes. The incidence of hypertension at the
mean follow-up time of 5.6 years was 5.7% and 3.7% in
men and women, respectively.Table 2 Odds ratio for incident hypertension in middle-aged





Model 1* IFG vs. NFG 1.95 (1.21-3.15)
Model 2** IFG vs. NFG 1.66 (1.02-2.70)
Age (years) 1.04 (1.00-1.08)
BMI (kg/m2) 1.06 (0.95-1.17)
SBP (mmHg) 1.12 (1.07-1.18)
TC (per 10 mg/dL) 1.03 (0.95-1.11)
TG (per 10 mg/dL) 1.03 (1.00-1.06)
HDL-C (per 10 mg/dL) 1.00 (0.80-1.25)
UA (mg/dL) 1.10 (0.90-1.34)
*Model 1: adjusted for age.
**Model 2: adjusted for age, BMI, SBP, TC, TG, HDL-C, and UA.
FPG, fasting plasma glucose; NFG, normal fasting glucose; IFG, impaired fasting glucThe incidence of hypertension in the FPG categories
and the multivariate-adjusted ORs for developing hyper-
tension in subjects with OBP and IFG when compared
with NFG by sex are given in Table 2. The age-adjusted
OR (shown as Model 1) for the development of hyper-
tension was 1.95 (95% CI, 1.21–3.15) and 3.54 (95% CI,
2.00–6.27) for men and women, respectively. After
adjusting for age, BMI, SBP, TC, TG, HDL-C and UA,
the OR (shown as Model 2) for hypertension was 1.66
(95% CI, 1.02–2.70) and 2.62 (95% CI, 1.45–4.73) for
men and women, respectively. Age and SBP in both
sexes and BMI in women also remained as predictors of
incident hypertension. The IFG in both sexes was
significantly and positively associated with the risk of
hypertension.
Discussion
The main finding of this study was that IFG may act
as an independent risk factor for the development of
hypertension in middle-aged healthy Japanese subjects
with OBP. In 1997, after the ADA introduced IFG1997
[5], various prospective studies have demonstrated
that impaired glucose tolerance (IGT), another form
of dysglycemia, was an independent risk factor for
incident hypertension [4,19-21]. However, the results
from previous investigations of the association between
IFG1997 or elevated FPG and the risk for hypertension
are conflicting [6-10], with 3 positive and 2 negative
results.
This study has some methodological strengths as com-
pared with previous studies. First, our cohort population
was relatively large and had a single homogenous ethni-
city. Second, all subjects were examined at one site, andJapanese subjects with OBP by sex
en Women
ypertension, (%) Incidence of hypertension, (%)
8 (4.5%) 43/1453 (2.9%)
9 (8.6%) 19/158 (10.7%)
P-value OR (95% CI) P-value
0.006 3.54 (2.00-6.27) <0.001
0.043 2.62 (1.45-4.73) 0.001
0.046 1.05 (1.00-1.10) 0.042
0.332 1.17 (1.06-1.29) 0.002
<0.001 1.09 (1.05-1.14) <0.001
0.478 0.94 (0.86-1.04) 0.228
0.079 1.06 (0.99-1.12) 0.079
1.000 0.96 (0.75-1.22) 0.727
0.361 1.17 (0.89-1.55) 0.268
ose.
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method both at baseline and follow-up.
Our study had several limitations. First, we could not
include several possible confounding variables that are
known hypertension risk factors, such as plasma insulin,
family history, alcohol and salt consumption, smoking,
waist circumference, and socioeconomic status. These
variables could be relevant for explaining the relation-
ship between IFG and the risk for hypertension. Second,
incident hypertension was defined by a single basal
measurement of blood pressure, which was repeated at
follow-up, or by a self-reported clinical diagnosis of
hypertension. Third, the study subjects were men and
women who had regular check-ups at a medical center
in Tokyo, and they may be a healthier subset of the
general population.
In summary, this study demonstrated an association
between IFG and the development of hypertension
among relatively lean Japanese subjects with OBP after
the ADA lowered the FPG threshold value for IFG from
110 to 100 mg/dL in 2003. The findings may help
clinicians identify those who are at higher risk for
hypertension.
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